Veeva Systems Inc. $VEEV Stake Trimmed by Brown Capital Management LLC

Brown Capital Management LLC decreased its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 34.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 363,997 shares of the technology company’s stock after selling 192,855 shares during the quarter. Veeva Systems comprises about 4.5% of Brown Capital Management LLC’s portfolio, making the stock its 3rd biggest holding. Brown Capital Management LLC owned approximately 0.22% of Veeva Systems worth $108,438,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Sigma Planning Corp raised its holdings in Veeva Systems by 1.2% in the 2nd quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock valued at $958,000 after acquiring an additional 39 shares during the last quarter. Private Trust Co. NA grew its position in shares of Veeva Systems by 17.1% in the third quarter. Private Trust Co. NA now owns 281 shares of the technology company’s stock valued at $84,000 after purchasing an additional 41 shares in the last quarter. Keybank National Association OH grew its position in shares of Veeva Systems by 1.4% in the second quarter. Keybank National Association OH now owns 3,088 shares of the technology company’s stock valued at $889,000 after purchasing an additional 42 shares in the last quarter. Apollon Wealth Management LLC increased its holdings in shares of Veeva Systems by 1.5% in the third quarter. Apollon Wealth Management LLC now owns 2,905 shares of the technology company’s stock valued at $865,000 after purchasing an additional 42 shares during the last quarter. Finally, Baron Wealth Management LLC lifted its position in Veeva Systems by 1.7% during the third quarter. Baron Wealth Management LLC now owns 2,447 shares of the technology company’s stock worth $729,000 after buying an additional 42 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

VEEV has been the subject of several analyst reports. Truist Financial upgraded Veeva Systems from a “hold” rating to a “buy” rating in a report on Thursday, January 8th. Needham & Company LLC reissued a “buy” rating and set a $355.00 price target on shares of Veeva Systems in a research report on Friday, November 21st. KeyCorp reissued a “sector weight” rating on shares of Veeva Systems in a report on Friday, December 12th. BMO Capital Markets assumed coverage on shares of Veeva Systems in a research report on Thursday, November 13th. They set a “market perform” rating and a $300.00 price objective for the company. Finally, TD Cowen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating and boosted their target price for the company from $297.00 to $380.00 in a report on Tuesday, October 7th. Eighteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $308.04.

Insider Buying and Selling at Veeva Systems

In related news, insider Thomas D. Schwenger sold 1,000 shares of the stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider owned 23,204 shares of the company’s stock, valued at approximately $5,370,101.72. This represents a 4.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 10.30% of the company’s stock.

Veeva Systems Trading Down 0.4%

Shares of VEEV opened at $203.14 on Tuesday. The company’s 50-day moving average price is $226.59 and its 200 day moving average price is $263.97. Veeva Systems Inc. has a 12-month low of $200.24 and a 12-month high of $310.50. The firm has a market cap of $33.39 billion, a P/E ratio of 39.52, a price-to-earnings-growth ratio of 1.51 and a beta of 1.08.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.95 by $0.09. The business had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. Veeva Systems had a net margin of 27.93% and a return on equity of 13.68%. The business’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same period last year, the business earned $1.75 earnings per share. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Equities research analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Veeva Systems announced that its Board of Directors has initiated a stock buyback program on Monday, January 5th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the technology company to buy up to 5.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.